1.
Yuan Y, DeMott MS, Byrne SR, et al. Phosphorothioate DNA modification by BREX Type 4 systems in the human gut microbiome. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.06.03.597175.
1.
Kumbhari A, Cheng TNH, Ananthakrishnan AN, et al. Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases. Cell host & microbe. 2024. doi:10.1016/j.chom.2024.05.022.
1.
Ciorba MA, Konnikova L, Hirota SA, et al. Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms. Inflammatory bowel diseases. 2024;30(Supplement_2):S5-S18. doi:10.1093/ibd/izae081.
1.
Li C, Stražar M, Mohamed AMT, et al. Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell. 2024. doi:10.1016/j.cell.2024.03.014.
1.
Oh J, Lee M, Park J, et al. Prenatal and postnatal exposure to antibiotics and risk of food allergy in the offspring: A nationwide birth cohort study in South Korea. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2024;35(3):e14114. doi:10.1111/pai.14114.
1.
Bhosle A, Bae S, Zhang Y, et al. Integrated annotation prioritizes metabolites with bioactivity in inflammatory bowel disease. Molecular systems biology. 2024. doi:10.1038/s44320-024-00027-8.
1.
Tekle GE, Andreeva N, Garrett WS. The Role of the Microbiome in the Etiopathogenesis of Colon Cancer. Annual review of physiology. 2024;86:453-478. doi:10.1146/annurev-physiol-042022-025619.
1.
Arya S, George AB, O’Dwyer JP. Sparsity of higher-order landscape interactions enables learning and prediction for microbiomes. Proceedings of the National Academy of Sciences of the United States of America. 2023;120(48):e2307313120. doi:10.1073/pnas.2307313120.
1.
Schirmer M, Stražar M, Avila-Pacheco J, et al. Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course. Cell host & microbe. 2024. doi:10.1016/j.chom.2023.12.013.
1.
Nguyen LH, Okin D, Drew DA, et al. Metagenomic assessment of gut microbial communities and risk of severe COVID-19. Genome medicine. 2023;15(1):49. doi:10.1186/s13073-023-01202-6.